SCHEMBL21794007

SCHEMBL21794007

COc1ccc(CN(Sc2cc(C(F)(F)F)c(F)cn2)c2cccc(F)n2)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP1A2 P05177 5/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2C19 P33261 5/20 0.38
TSHR P16473 5/20 0.38
CYP2D6 P10635 4/20 0.38
ALOX15 P16050 2/20 0.38
USP2 O75604 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.35
DHFR P00374 1/20 0.33
EGFR P00533 1/20 0.32
PDE4B Q07343 1/20 0.32
POLB P06746 1/20 0.32
MAPK10 P53779 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783377 0.88 MEN1 (0.37) GAAKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL21783395 0.81 KMT2A (0.36) GAAKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL20256741 0.79 KMT2A (0.35) GAAKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL21773230 0.79 GAA (0.43) GAAKDM4EALDH1A1TDP1CYP1A2
SCHEMBL30845640 0.79 GAA (0.43) GAAKDM4EALDH1A1TDP1CYP1A2
SCHEMBL21794112 0.78 EPHX2 (0.44) GAAKDM4EALDH1A1TDP1MEN1
SCHEMBL21783445 0.76 CYP1A2 (0.35) GAAKDM4EALDH1A1TDP1CYP1A2
SCHEMBL21783444 0.76 KMT2A (0.37) GAAKDM4EALDH1A1TDP1CYP1A2
SCHEMBL19634258 0.76 HTR2A (0.38) KDM4EALDH1A1TDP1CYP1A2CYP3A4
SCHEMBL19634018 0.76 MEN1 (0.39) KDM4EALDH1A1TDP1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047312-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed